Quarterly Consolidated Balance Sheet

OncoTherapy Science, Inc. - Filing #7720896

Concept As at
2018-06-30
As at
2018-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
5,894,579,000 JPY
6,740,238,000 JPY
Raw materials and supplies
16,453,000 JPY
14,558,000 JPY
Other
264,510,000 JPY
195,403,000 JPY
Current assets
6,267,008,000 JPY
7,034,066,000 JPY
Non-current assets
Property, plant and equipment
579,029,000 JPY
581,970,000 JPY
Property, plant and equipment
Intangible assets
Other
72,000 JPY
72,000 JPY
Intangible assets
256,969,000 JPY
284,938,000 JPY
Investments and other assets
116,450,000 JPY
120,548,000 JPY
Investments and other assets
Non-current assets
952,448,000 JPY
987,458,000 JPY
Assets
7,219,457,000 JPY
8,021,524,000 JPY
Liabilities
Current liabilities
Income taxes payable
1,376,000 JPY
5,170,000 JPY
Other
21,916,000 JPY
21,900,000 JPY
Current liabilities
222,198,000 JPY
306,135,000 JPY
Non-current liabilities
Asset retirement obligations
123,088,000 JPY
122,611,000 JPY
Non-current liabilities
135,629,000 JPY
135,549,000 JPY
Liabilities
357,827,000 JPY
441,685,000 JPY
Net assets
Shareholders' equity
Share capital
50,455,000 JPY
50,455,000 JPY
Capital surplus
21,313,985,000 JPY
21,313,985,000 JPY
Retained earnings
-15,026,589,000 JPY
-14,379,482,000 JPY
Shareholders' equity
6,337,852,000 JPY
6,984,958,000 JPY
Valuation and translation adjustments
Foreign currency translation adjustment
-9,067,000 JPY
-9,250,000 JPY
Valuation and translation adjustments
-9,067,000 JPY
-9,250,000 JPY
Share acquisition rights
329,097,000 JPY
347,277,000 JPY
Non-controlling interests
203,748,000 JPY
256,853,000 JPY
Net assets
6,861,630,000 JPY
7,579,839,000 JPY
Liabilities and net assets
7,219,457,000 JPY
8,021,524,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.